Abstract
We report a patient with a history of leukopenia who developed acute myeloid leukemia (AML) FAB M2 and was successfully treated with induction and consolidation chemotherapy. She relapsed 7 months after initial diagnosis. Peripheral blood cells at relapse showed a t(12;15)(p13;q13), which has not been previously described in de novo or relapsed AML.
Original language | English (US) |
---|---|
Pages (from-to) | 165-167 |
Number of pages | 3 |
Journal | Cancer Genetics and Cytogenetics |
Volume | 86 |
Issue number | 2 |
DOIs | |
State | Published - Feb 1996 |
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Cancer Research